Rankings
▼
Calendar
ENGN FY 2024 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena
ENGN
enGene Holdings Inc.
$359M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$323,000
Operating Income
$62M
Net Income
-$55M
EPS (Diluted)
$-1.46
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$49M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$311M
Total Liabilities
$39M
Stockholders' Equity
$273M
Cash & Equivalents
$173M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$323,000
-$175,000
-84.6%
Operating Income
$62M
-$26M
+339.1%
Net Income
-$55M
-$100M
+44.8%
← Q4 2023
All Quarters
Q1 2024 →